[1]
Rozpędek, W.; Pytel, D.; Nowak-Zduńczyk, A.; Lewko, D.; Wojtczak, R.; Diehl, J.A.; Majsterek, I. Breaking the DNA damage response via serine/threonine kinase inhibitors to improve cancer treatment. Curr. Med. Chem., 2019, 26(8), 1425-1445.
[2]
Toma, M.; Skorski, T.; Sliwinski, T. DNA double strand break repair - related synthetic lethality. Curr. Med. Chem., 2019, 26(8), 1446-1482.
Current Medicinal Chemistry
Title:DNA Damage Response as a Pharmacological Target for Cancer and Infectious Diseases
Volume: 26 Issue: 8
Author(s): Tomasz Poplawski
Affiliation:
Export Options
About this article
Cite this article as:
Poplawski Tomasz , DNA Damage Response as a Pharmacological Target for Cancer and Infectious Diseases, Current Medicinal Chemistry 2019; 26 (8) . https://dx.doi.org/10.2174/092986732608190516092613
DOI https://dx.doi.org/10.2174/092986732608190516092613 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
28
6
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Highly Efficient, Chemoselective Syntheses of 2-Methoxy-4-substituted Pyrimidines
Letters in Organic Chemistry Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy
Protein & Peptide Letters TGF-Beta Inihibitor-loaded Polyelectrolyte Multilayers Capsules for Sustained Targeting of Hepatocarcinoma Cells
Current Pharmaceutical Design A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon
Anti-Cancer Agents in Medicinal Chemistry Challenge of Mesenchymal Stem Cells Against Diabetic Foot Ulcer
Current Stem Cell Research & Therapy Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial [ Infectious Diseases: What is in our future? ]
Infectious Disorders - Drug Targets Medullary Thyroid Cancer: A Promising Model for Targeted Therapy
Current Molecular Medicine Anti-Inflammatory Approaches that Target the Chemokine Network
Recent Patents on Inflammation & Allergy Drug Discovery Synthesis of Indolyl Pyrazole Scaffolds as Potential Anti-cancer Agents and their Molecular Modelling Studies
Letters in Drug Design & Discovery Diagnostic und Therapeutic Value of Cell-free Circulating DNA as a Non-invasive Biomarker in Patients with Prostate Cancer
Current Cancer Therapy Reviews Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration
Current Alzheimer Research Rho GTPase Activating Proteins in Cancer Phenotypes
Current Protein & Peptide Science Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry MARK1 is a Novel Target for miR-125a-5p: Implications for Cell Migration in Cervical Tumor Cells
MicroRNA Synthesis and Preliminary Biological Evaluation of Estrone Dimers
Letters in Drug Design & Discovery The Application of Proteomics for the Early Detection of Lung Cancer
Current Proteomics Molecular Mechanisms of Epithelial Regeneration and Neovascularization During Healing of Gastric and Esophageal Ulcers
Current Medicinal Chemistry Mitochondria-Targeting Anticancer Metal Complexes
Current Medicinal Chemistry